JP2023531506A5 - - Google Patents
Info
- Publication number
- JP2023531506A5 JP2023531506A5 JP2022579664A JP2022579664A JP2023531506A5 JP 2023531506 A5 JP2023531506 A5 JP 2023531506A5 JP 2022579664 A JP2022579664 A JP 2022579664A JP 2022579664 A JP2022579664 A JP 2022579664A JP 2023531506 A5 JP2023531506 A5 JP 2023531506A5
- Authority
- JP
- Japan
- Prior art keywords
- crispr
- tnt
- cells
- regulatory protein
- based genome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042909P | 2020-06-23 | 2020-06-23 | |
| US63/042,909 | 2020-06-23 | ||
| PCT/US2021/038588 WO2021262788A2 (en) | 2020-06-23 | 2021-06-23 | Tunneling nanotube cells and methods of use thereof for delivery of biomolecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531506A JP2023531506A (ja) | 2023-07-24 |
| JP2023531506A5 true JP2023531506A5 (enExample) | 2024-06-28 |
Family
ID=79166615
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579664A Withdrawn JP2023531506A (ja) | 2020-06-23 | 2021-06-23 | トンネルナノチューブ細胞および生体分子の送達のためのその使用方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20220002718A1 (enExample) |
| EP (1) | EP4168560A4 (enExample) |
| JP (1) | JP2023531506A (enExample) |
| CN (1) | CN116194755A (enExample) |
| AU (1) | AU2021296822A1 (enExample) |
| CA (1) | CA3187571A1 (enExample) |
| WO (1) | WO2021262788A2 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114258398A (zh) | 2019-06-13 | 2022-03-29 | 总医院公司 | 工程化的人内源性病毒样颗粒及使用其递送至细胞的方法 |
| CN116670154A (zh) | 2020-07-24 | 2023-08-29 | 总医院公司 | 增强的病毒样颗粒及使用其递送至细胞的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013151663A1 (en) * | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of membrane proteins |
| AU2016255535A1 (en) * | 2015-04-30 | 2017-11-16 | University Of Southern California | Secretory TNT CAR cell immunotherapy |
| US20190008896A1 (en) * | 2017-07-07 | 2019-01-10 | Richard Postrel | Methods and Systems for the Prevention, Treatment and Management of Disease and Effects of Aging Via Cell-to-Cell Restoration Therapy Using Subcellular Transactions |
-
2021
- 2021-06-23 US US17/355,638 patent/US20220002718A1/en not_active Abandoned
- 2021-06-23 WO PCT/US2021/038588 patent/WO2021262788A2/en not_active Ceased
- 2021-06-23 CN CN202180051764.1A patent/CN116194755A/zh not_active Withdrawn
- 2021-06-23 EP EP21829644.0A patent/EP4168560A4/en not_active Withdrawn
- 2021-06-23 JP JP2022579664A patent/JP2023531506A/ja not_active Withdrawn
- 2021-06-23 CA CA3187571A patent/CA3187571A1/en active Pending
- 2021-06-23 AU AU2021296822A patent/AU2021296822A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023535726A5 (enExample) | ||
| AU2018306307B2 (en) | Enhanced chimeric antigen receptors and use thereof | |
| ES2634705T3 (es) | Identificación de antígenos de superficie celular, asociados a tumor para diagnóstico y terapia | |
| KR20220009980A (ko) | 조절된 합성 유전자 발현 시스템 | |
| GB2613486A (en) | Enhanced virus-like particles and methods of use thereof for delivery to cells | |
| JP2009268467A5 (enExample) | ||
| CN107614012A (zh) | 使用工程化的细胞检测、监测或治疗疾病或病况的系统及制备和使用它们的方法 | |
| JP2007297407A5 (enExample) | ||
| CA2868429A1 (en) | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins | |
| MacLeod et al. | Regulation of CAT: cationic amino acid transporter gene expression | |
| Hwang et al. | Proteins differentially expressed in response to nicotine in five rat brain regions: Identification using a 2‐DE/MS‐based proteomics approach | |
| KR20200146018A (ko) | 해산물 알레르기의 진단 방법 및 제품 | |
| Rio et al. | High yield purification of active transcription factor IIIA expressed in E. coli | |
| JP2025515134A (ja) | 疾患細胞の位置を決定するおよび／または疾患細胞を処置するために表面発現可能な活性化可能エピトープを使用する方法 | |
| Liu | Protein Structure and Function | |
| CN104673818A (zh) | 猪rbp4蛋白体外表达及其抗体制备 | |
| WO2004038003A2 (en) | Human polypeptides encoded by polynucleotides and methods of their use | |
| WO2004020591A2 (en) | Methods of use for novel human polypeptides encoded by polynucleotides | |
| JP5892648B2 (ja) | Ｄｄｓカプセル用タンパク質およびそれを用いた薬剤とその調整方法 | |
| Cao et al. | The SLC41 Family of Magnesium Transporters: Molecular Regulators of Magnesium Homeostasis and Their Multifaceted Roles in Human Diseases | |
| Chertkov et al. | Purification of RNA polymerase elongation complexes for cryoelectron microscopy investigation | |
| Heidelberger et al. | HISTORY OF PROTEIN STRUCTURE AND FUNCTION STUDY Proteins are macromolecules made up of one or more long chains of amino acids (including 20 standard amino acids as well as selenocysteine and pyrrolysine in archaea and | |
| WO2005053740A1 (ja) | 免疫増強剤およびこれを用いた強化抗原 | |
| JP2018082622A (ja) | 免疫沈降用の内部標準分子及び免疫沈降方法 | |
| Khowal et al. | In silico analyses of the human sperm‐specific antigen 2 and its role in oral squamous cell carcinoma |